Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CADLCADL
15 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CANDEL THERAPEUTICS INC

CITADEL ADVISORS LLC holds 146,016 shares of CADL (CANDEL THERAPEUTICS INC), worth $1.5M as of 2026-Q2. The position was increased (+100.9% shares). CADL represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$1.5M

Current Shares

146,016

Total Value Change

+$1.5M

Total Shares Change

+129,165

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
146,016
+100.9%
$1.5M0.0%$10.30
41
2026-Q1
Decreased
72,666
-67.9%
$356,0630.0%$4.91
0
2025-Q4
Decreased
226,356
-10.3%
$1.3M0.0%$5.71
0
2025-Q3
New
252,291
-
$1.3M0.0%$5.40
35
2025-Q2
Exited
0
-100.0%
$00.0%$4.90
0
2025-Q1
Decreased
9,636
-96.7%
$54,4430.0%$5.95
0
2024-Q4
Increased
291,149
+2882x
$2.5M0.0%$7.95
42
2024-Q3
New
101
-
$7000.0%$7.21
17
2024-Q1
Exited
0
-100.0%
$00.0%$1.58
0
2023-Q4
Decreased
16,852
-47.6%
$24,7720.0%$1.47
0
2023-Q3
New
32,152
-
$29,9010.0%$0.92
30
2023-Q2
Exited
0
-100.0%
$00.0%$1.24
0
2023-Q1
New
47,174
-
$64,6280.0%$1.38
32
2022-Q4
Exited
0
-100.0%
$00.0%$1.79
0
2022-Q3
New
16,851
-
$53,0000.0%$3.20
32

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used